Tobias Maurer
Has participated in:
-
Molekulare Diagnostik und Therapie in der Uro-Onkologie : am Beispiel der 11C-Cholin-PET, CT beim Blasen- und Prostatakarzinom sowie der CpG-basierten Immuntherapie des Prostatakarzinoms
-
Limited prognostic role of routine serum markers (AP, CEA, LDH and NSE) in oligorecurrent prostate cancer patients undergoing PSMA-radioguided surgery
-
Histologically confirmed diagnostic efficacy of 18F-rhPSMA-7 PET for staging of patients with primary high-risk prostate cancer
-
18F-rhPSMA7 for biochemichal recurrence in prostate cancer